CV Shariat_AKH - Vienna OMI

More documents

Recommendations

Info

• European Association of Urology (Europe) 1999• Endourological Society (USA) 1999• American Association for Cancer Research (USA) 1999• American Society of Clinical Oncology (USA) 1999• Society of Basic Urologic Research (USA) 2000• Association of U.S. Trained European Physicians (USA); Founder 2000• American Association of Clinical Urologists, Inc. (USA) 2001• Bladder Cancer Research Consortium (International); Founder and Director 2002• Texas Medical Association (USA) 2003• American Urological Association (USA) 2004• Society of Urologic Oncology (USA) 2004• Bladder Cancer Early Detection Network (International); Founder and Director 2006• American College of Surgeons (USA) 2008• Upper Tract Urothelial Carcinoma Collaboration (International); Founder and Director 2008• International Bladder Cancer Network (IBCN) 2008• Bladder Cancer Advocacy Network (North America) 2010• Österreichische Gesellschaft für Urologie und Andrologie (Austria) 2011Arbeitskreis: Geschlechtsspezifische Medizin in der Urologie• Academic Men´s Health Network (International) 2011• Foundation for Men's Health (FMH); oncology-related advisory committee 2011• American Society of Men's Health (ASMH); Executive committee and board of directors 2011• Minimally Invasive Robotic Association (International) 2011• Society of University Urologists (USA) 2011• Iranian American Urological Society (North American); Co-founder and member 2012• New York Academy of Sciences (USA)2012• New York Section of the American Urological Association (USA)2012HONORS & AWARDS (selected from 62)• Award for the First Term of Studies 1995Dean of the University of Vienna - Medical School (Austria)• “Matricula de Honor” Honorary Award for best student in 1995/1996 1996University of La Laguna - Medical School (Spain)• Award for the Second Term of Studies 1997Dean of the University of Vienna - Medical School (Austria)• Performance Grant for Outstanding Study Success in 1996/1997 1997Dean of the University of Vienna – Medical School (Austria)• Performance Grant for Outstanding Study Success in 1997/1998 1998Dean of the University of Vienna - Medical School (Austria)• Andlinger Educational Fellowship Grant, American-Austrian Foundation (USA) 1998• Young Investigator Award, Hans und Rosa Blanca Foundation (Austria) 1999• Performance Grant for Outstanding Achievements in Research 1999Dean of the University of Vienna - Medical School (Austria)• Grant, Methods in Clinical Cancer Research. Vail, Colorado 1999The American Association for Cancer Research and the American Society of ClinicalOncology• Travel Grant, Molecular Biology in Clinical Oncology. Aspen, Colorado 2000The American Association for Cancer Researchwww.vienna-omi.at 28.08.2013
• Glaxo SmithKline Scholar Award, for promising clinical/translational cancer research 2001American Association of Cancer Research• Pfizer Scholar in Urology Award• Winner of the Science Day 2001 Project – Baylor College of Medicine, Houston, TX 2001• First Place Poster 20012nd Alexander Research Symposium, Baylor College of Medicine, Houston, TXExpression of TGF-β1 and its receptors in transitional cell carcinoma of the bladder.• AUA / Praecis Gerald P. Murphy Scholar 2002• American Cancer Society Institutional Research Grant (IRG#93-034-06) 2002Development of a nomogram for prediction of the development of distant prostate cancermetastases and mortality.• Best Poster 2002Society of Urologic Oncology Annual Meeting, National Cancer Institute,December 13 - 14, 2002, National Institutes of Health, Bethesda, Maryland.Preoperative serum levels of pro-PSA isoforms are associated with biologicallyaggressive prostate cancer.• 2000 Outstanding Intellectuals of the 21st Century 2003International Biographical Center, Cambridge, England (Registration number 965274)• Best Poster 2004Society for Urodynamics and Female Urology 2004 Meeting. Scottsdale, Arizona.February 26-29, 2004.• “Best Poster” in urothelial cancer 2004European Association of Urology Annual Meeting, Vienna, March 26, 2004.Urine detection of survivin is a sensitive marker for the non-invasive diagnosis ofbladder cancer.• “Best Poster” in urogenital trauma 200521st European Association of Urology Annual Meeting, Paris, April 5-8, 2006.Evidence-based validation of the predictive value of the American Association for theSurgery of Trauma kidney injury scale.• “Best Poster” in bladder cancer: diagnosis and staging III 200621st European Association of Urology Annual Meeting, Paris, April 5-8, 2006. Survivinexpression is associated with bladder cancer presence, stage, progression, metastasis, andmortality.• AUA / Threshold Pharmaceuticals Gerald P. Murphy Scholar 2006• AUA / Novacea Gerald P. Murphy Scholar 2007• Listed in the “Guide to America’s Top Urologists 2007” – Consumers’ Research 2007Council of America is an independent research company based in Washington, DC thatevaluated professional services throughout America (www.consumerresearchcncl.org).• “Best Poster” in prostate cancer: staging I 200722nd European Association of Urology Annual Meeting, Berlin, March 21-4, 2007.Caveolin-1 overexpression is associateat with aggressive prostate cancer recurrence.• Best Poster 2007Society of Urologic Oncology Eight Annual Meeting, National Cancer Institute, November29th-December 1st, 2007, National Institutes of Health, Bethesda, Maryland.Multiple bio-markers for the prediction of bladder cancer recurrence and mortality.• “Best Poster” in prostate cancer: prognostic factors and predictors of outcome 200823rd European Association of Urology Annual Meeting, Milano, Italy. March 26-9, 2008.Early post-operative plasma transforming growth factor-β1 is a powerful predictor ofwww.vienna-omi.at 28.08.2013
Page 1 and 2: SHAHROKH F. SHARIAT, MDProfessor an
Page 3: E D U C A T I O N & M E D I C A L T
Page 7 and 8: May 29-June 3, 2010. J.Urol 183(4):
Page 9 and 10: • Leading Physician of the World
Page 11 and 12: Weill Cornell Medical Center, Princ
Page 13 and 14: Inventor: Shahrokh ShariatThe prese
Page 15 and 16: • Chair of Sessions - The Inaugur
Page 17 and 18: • Guest Editor of special issue o
Page 19 and 20: • Visiting Professor, Division of
Page 21 and 22: Ablative therapy for small renal co
Page 23 and 24: Bladder cancer: opportunities for i
Page 25 and 26: 7. Merseburger AS, Herrmann TR, Sha
Page 27 and 28: 36. May M, Ficarra V, Shariat SF, Z
Page 29 and 30: Results from of a Large Multicenter
Page 31 and 32: trends and disparities in the use o
Page 33 and 34: 112. Abdollah F, Sun M, Thuret R, J
Page 35 and 36: 139. Fajkovic H, Cha EK, Jeldres C,
Page 37 and 38: RK, Margulis V, Shariat SF: Tissue-
Page 39 and 40: 21869907190. Abdollah F, Sun M, Jel
Page 41 and 42: Montorsi F, Karakiewicz PI: The imp
Page 43 and 44: Fradet Y, Shariat SF. Prognostic ri
Page 45 and 46: 271. Shariat SF, Lotan Y, Vickers A
Page 47 and 48: 298. Shariat SF, Kattan MW, Vickers
Page 49 and 50: 324. Capitanio U, Isbarn H, Shariat
Page 51 and 52: 349. Margulis V, Shariat SF, Matin
Page 53 and 54: 378. Karakiewicz PI, Bhojani N, Cap
Page 55 and 56:
410. Shariat SF, Lamb DJ, Iyengar R
Page 57 and 58:
442. Chun FK, Briganti A, Gallina A
Page 59 and 60:
cystectomy for primary nontransitio
Page 61 and 62:
Slawin KM. Salvage radiotherapy for
Page 63 and 64:
535. Shariat SF, Desai S, Song W, K
Page 65 and 66:
21. SunM., Abdollah F., Schmitges J
Page 67 and 68:
progression after radical prostatec
Page 69 and 70:
Y., Karakiewicz P.: Assessement of
Page 71 and 72:
50. Shariat S., Karakiewicz P., Fra
Page 73 and 74:
predictions in patients with adreno
Page 75 and 76:
Schoenberg, G. E. Amiel, S. P. Lern
Page 77 and 78:
113. Claudio Jeldres, Maxime Crepel
Page 79 and 80:
(volume 183 issue 4 Page e227)134.
Page 81 and 82:
156. Ramy Youssef, Shahrokh Shariat
Page 83 and 84:
Localized .Sunday, May 15, 2011 Ame
Page 85 and 86:
Health Conference. 2-5 October 2011
Page 87 and 88:
urothelial carcinoma. Poster #155.
Page 89 and 90:
supplementation on the prevention o
Page 91 and 92:
for metastatic renal cell carcinoma
Page 93 and 94:
muscle-invasive urothelial carcinom
Page 95 and 96:
Shahrokh Shariat Prediction of intr
Page 97 and 98:
Terrone; Derya Tilki; Daniel Vergho
Page 99 and 100:
P.I.: Drs. Shahrokh Shariat and Dou
show all

CV Shariat_AKH - Vienna OMI

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?